In contrast, the presence of the sera from RRMS patients did not significantly affect the migration of healthy subject T regulatory (Treg) cells (CD4+ Foxp3+) when compared to RRMS patient cells (Fig. 2b). This evidence concerns the gene FOXP3 and relapsing-remitting multiple sclerosis.